Trial ID or NCT#

NCT03784924

Status

recruiting iconRECRUITING

Purpose

The commercialization of MRI fusion biopsies has resulted in a dramatic increase in the use of MRI imaging for prostate cancer. How best to use MRI in the initial prostate biopsy setting given the availability of validated prostate cancer early detection markers is uncertain.This study will allow investigators to determine if prostate MRI is superior to validated panel of laboratory biomarkers (e.g. PCA3, PSA and TMPRSS2:ERG) in the initial biopsy setting.

Official Title

EDRN Prostate MRI Biomarker Study and Reference Set

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: Male
Accepts Healthy Volunteers: No

Investigator(s)

Geoffrey Sonn
Geoffrey Sonn
Urologic oncologist, Urologist, Urologic specialist, Genitourinary specialist
Assistant Professor of Urology and, by courtesy, of Radiology at the Stanford University Medical Center

Contact us to find out if this trial is right for you.

CONTACT

Daniel Alvarez
(650) 723-0948